Accendra Health Inc (ACH) stock
ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.13−0.01 (-9.59%)
Close on Nov 13, 2026Market cap $10.15MP/E –Yield –
Accendra Health total assets
Total assets on the balance sheet at the end of each period.
Accendra Health's total assets was $2.08B at Sep 30, 2026. For fiscal 2025 it was $2.45B, down 47.3% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is $5.39B in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.45B | -47.3% |
| FY2024 | Dec 31, 2024 | $4.66B | -8.6% |
| FY2023 | Dec 31, 2023 | $5.09B | -5.4% |
| FY2022 | Dec 31, 2022 | $5.39B | +52.3% |
| FY2021 | Dec 31, 2021 | $3.54B | +6.0% |
| FY2020 | Dec 31, 2020 | $3.34B | -8.4% |
| FY2019 | Dec 31, 2019 | $3.64B | -3.5% |
| FY2018 | Dec 31, 2018 | $3.77B | +11.8% |
| FY2017 | Dec 31, 2017 | $3.38B | +24.2% |
| FY2016 | Dec 31, 2016 | $2.72B | -2.0% |
| FY2015 | Dec 31, 2015 | $2.77B | +1.4% |
| FY2014 | Dec 31, 2014 | $2.74B | +17.7% |
| FY2013 | Dec 31, 2013 | $2.32B | +5.0% |
| FY2012 | Dec 31, 2012 | $2.21B | +13.7% |
| FY2011 | Dec 31, 2011 | $1.95B | +6.8% |
| FY2010 | Dec 31, 2010 | $1.82B | +4.3% |
| FY2009 | Dec 31, 2009 | $1.75B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.08B | -48.5% |
| Q2 FY2026 | Jun 30, 2026 | $2.11B | -49.3% |
| Q1 FY2026 | Mar 31, 2026 | $2.42B | -50.3% |
| Q4 FY2025 | Dec 31, 2025 | $2.45B | -47.3% |
| Q3 FY2025 | Sep 30, 2025 | $4.04B | -20.6% |
| Q2 FY2025 | Jun 30, 2025 | $4.15B | -21.7% |
| Q1 FY2025 | Mar 31, 2025 | $4.86B | -6.8% |
| Q4 FY2024 | Dec 31, 2024 | $4.66B | -8.6% |
| Q3 FY2024 | Sep 30, 2024 | $5.08B | -0.8% |
| Q2 FY2024 | Jun 30, 2024 | $5.30B | +0.3% |
| Q1 FY2024 | Mar 31, 2024 | $5.21B | -1.9% |
| Q4 FY2023 | Dec 31, 2023 | $5.09B | -5.4% |
| Q3 FY2023 | Sep 30, 2023 | $5.12B | -7.5% |
| Q2 FY2023 | Jun 30, 2023 | $5.29B | -4.8% |
| Q1 FY2023 | Mar 31, 2023 | $5.31B | -7.0% |
| Q4 FY2022 | Dec 31, 2022 | $5.39B | +52.3% |
| Q3 FY2022 | Sep 30, 2022 | $5.54B | +54.5% |
| Q2 FY2022 | Jun 30, 2022 | $5.56B | +54.7% |
| Q1 FY2022 | Mar 31, 2022 | $5.71B | +68.3% |
| Q4 FY2021 | Dec 31, 2021 | $3.54B | +6.0% |
| Q3 FY2021 | Sep 30, 2021 | $3.58B | +8.7% |
| Q2 FY2021 | Jun 30, 2021 | $3.59B | +14.5% |
| Q1 FY2021 | Mar 31, 2021 | $3.39B | -8.7% |
| Q4 FY2020 | Dec 31, 2020 | $3.34B | -8.4% |
| Q3 FY2020 | Sep 30, 2020 | $3.30B | -10.6% |
| Q2 FY2020 | Jun 30, 2020 | $3.14B | -19.5% |
| Q1 FY2020 | Mar 31, 2020 | $3.71B | -4.3% |
| Q4 FY2019 | Dec 31, 2019 | $3.64B | -3.5% |
| Q3 FY2019 | Sep 30, 2019 | $3.69B | -8.5% |
| Q2 FY2019 | Jun 30, 2019 | $3.90B | -3.6% |
| Q1 FY2019 | Mar 31, 2019 | $3.88B | +14.5% |
| Q4 FY2018 | Dec 31, 2018 | $3.77B | +11.8% |
| Q3 FY2018 | Sep 30, 2018 | $4.03B | +20.9% |
| Q2 FY2018 | Jun 30, 2018 | $4.04B | +44.6% |
| Q1 FY2018 | Mar 31, 2018 | $3.39B | +25.6% |
| Q4 FY2017 | Dec 31, 2017 | $3.38B | +24.2% |
| Q3 FY2017 | Sep 30, 2017 | $3.33B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.80B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.70B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.72B | – |
See a number that looks wrong?